United States Bio-protein Drug Market Report 2017

Name: United States Bio-protein Drug Market Report 2017
Brand: QYResearch
SKU: U82A23F3563EN
Price: 3800 USD
Availability: InStock

January 2018 | 109 pages | ID: U82A23F3563EN
QYResearch

US$ 3,800.00

E-mail Delivery (PDF)

Download PDF Leaflet

Wire Transfer

Checkout Later

Need Help? Ask a Question

In this report, the United States Bio-protein Drug market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:

The West
Southwest
The Middle Atlantic
New England
The South
The Midwest
with sales (volume), revenue (value), market share and growth rate of Bio-protein Drug in these regions, from 2012 to 2022 (forecast).

United States Bio-protein Drug market competition by top manufacturers/players, with Bio-protein Drug sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including

Abbott Laboratories
Bayer AG
Eli Lilly and Company
Amgen Inc.
Biocon Ltd.
Dr. Reddy’s Laboratories
Roche
Fresenius kabi
GlaxoSmithKline
Johnson & Johnson
Merck
Novartis AG
Panacea Biotec
ProBioGen AG
Sanofi
Reliance Life Science Pvt. Ltd.

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

Monoclonal Antibodies
Therapeutic Proteins
Vaccines

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

Pharma and Biotech Companies
CROs
Academics

If you have any special requirements, please let us know and we will offer you the report as you want.

United States Bio-protein Drug Market Report 2017

1 BIO-PROTEIN DRUG OVERVIEW

1.1 Product Overview and Scope of Bio-protein Drug
1.2 Classification of Bio-protein Drug by Product Category
  1.2.1 United States Bio-protein Drug Market Size (Sales Volume) Comparison by Type (2012-2022)
  1.2.2 United States Bio-protein Drug Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
  1.2.3 Monoclonal Antibodies
  1.2.4 Therapeutic Proteins
  1.2.5 Vaccines
1.3 United States Bio-protein Drug Market by Application/End Users
  1.3.1 United States Bio-protein Drug Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
  1.3.2 Pharma and Biotech Companies
  1.3.3 CROs
  1.3.4 Academics
1.4 United States Bio-protein Drug Market by Region
  1.4.1 United States Bio-protein Drug Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 The West Bio-protein Drug Status and Prospect (2012-2022)
  1.4.3 Southwest Bio-protein Drug Status and Prospect (2012-2022)
  1.4.4 The Middle Atlantic Bio-protein Drug Status and Prospect (2012-2022)
  1.4.5 New England Bio-protein Drug Status and Prospect (2012-2022)
  1.4.6 The South Bio-protein Drug Status and Prospect (2012-2022)
  1.4.7 The Midwest Bio-protein Drug Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Bio-protein Drug (2012-2022)
  1.5.1 United States Bio-protein Drug Sales and Growth Rate (2012-2022)
  1.5.2 United States Bio-protein Drug Revenue and Growth Rate (2012-2022)

2 UNITED STATES BIO-PROTEIN DRUG MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States Bio-protein Drug Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Bio-protein Drug Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Bio-protein Drug Average Price by Players/Suppliers (2012-2017)
2.4 United States Bio-protein Drug Market Competitive Situation and Trends
  2.4.1 United States Bio-protein Drug Market Concentration Rate
  2.4.2 United States Bio-protein Drug Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Bio-protein Drug Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES BIO-PROTEIN DRUG SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2012-2017)

3.1 United States Bio-protein Drug Sales and Market Share by Region (2012-2017)
3.2 United States Bio-protein Drug Revenue and Market Share by Region (2012-2017)
3.3 United States Bio-protein Drug Price by Region (2012-2017)

4 UNITED STATES BIO-PROTEIN DRUG SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2012-2017)

4.1 United States Bio-protein Drug Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Bio-protein Drug Revenue and Market Share by Type (2012-2017)
4.3 United States Bio-protein Drug Price by Type (2012-2017)
4.4 United States Bio-protein Drug Sales Growth Rate by Type (2012-2017)

5 UNITED STATES BIO-PROTEIN DRUG SALES (VOLUME) BY APPLICATION (2012-2017)

5.1 United States Bio-protein Drug Sales and Market Share by Application (2012-2017)
5.2 United States Bio-protein Drug Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 UNITED STATES BIO-PROTEIN DRUG PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 Abbott Laboratories
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Bio-protein Drug Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Abbott Laboratories Bio-protein Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Bayer AG
  6.2.2 Bio-protein Drug Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Bayer AG Bio-protein Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Eli Lilly and Company
  6.3.2 Bio-protein Drug Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Eli Lilly and Company Bio-protein Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Amgen Inc.
  6.4.2 Bio-protein Drug Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Amgen Inc. Bio-protein Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Biocon Ltd.
  6.5.2 Bio-protein Drug Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Biocon Ltd. Bio-protein Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 Dr. Reddy’s Laboratories
  6.6.2 Bio-protein Drug Product Category, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Dr. Reddy’s Laboratories Bio-protein Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 Roche
  6.7.2 Bio-protein Drug Product Category, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Roche Bio-protein Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 Fresenius kabi
  6.8.2 Bio-protein Drug Product Category, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Fresenius kabi Bio-protein Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview
6.9 GlaxoSmithKline
  6.9.2 Bio-protein Drug Product Category, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 GlaxoSmithKline Bio-protein Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Main Business/Business Overview
6.10 Johnson & Johnson
  6.10.2 Bio-protein Drug Product Category, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 Johnson & Johnson Bio-protein Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.10.4 Main Business/Business Overview
6.11 Merck
6.12 Novartis AG
6.13 Panacea Biotec
6.14 ProBioGen AG
6.15 Sanofi
6.16 Reliance Life Science Pvt. Ltd.

7 BIO-PROTEIN DRUG MANUFACTURING COST ANALYSIS

7.1 Bio-protein Drug Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Bio-protein Drug

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Bio-protein Drug Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Bio-protein Drug Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES BIO-PROTEIN DRUG MARKET SIZE (VALUE AND VOLUME) FORECAST (2017-2022)

11.1 United States Bio-protein Drug Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Bio-protein Drug Sales Volume Forecast by Type (2017-2022)
11.3 United States Bio-protein Drug Sales Volume Forecast by Application (2017-2022)
11.4 United States Bio-protein Drug Sales Volume Forecast by Region (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.

LIST OF TABLES AND FIGURES

Figure Product Picture of Bio-protein Drug
Figure United States Bio-protein Drug Market Size (K Units) by Type (2012-2022)
Figure United States Bio-protein Drug Sales Volume Market Share by Type (Product Category) in 2016
Figure Monoclonal Antibodies Product Picture
Figure Therapeutic Proteins Product Picture
Figure Vaccines Product Picture
Figure United States Bio-protein Drug Market Size (K Units) by Application (2012-2022)
Figure United States Sales Market Share of Bio-protein Drug by Application in 2016
Figure Pharma and Biotech Companies Examples
Table Key Downstream Customer in Pharma and Biotech Companies
Figure CROs Examples
Table Key Downstream Customer in CROs
Figure Academics Examples
Table Key Downstream Customer in Academics
Figure United States Bio-protein Drug Market Size (Million USD) by Region (2012-2022)
Figure The West Bio-protein Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Bio-protein Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Bio-protein Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Bio-protein Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Bio-protein Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Bio-protein Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Bio-protein Drug Sales (K Units) and Growth Rate (2012-2022)
Figure United States Bio-protein Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Bio-protein Drug Market Major Players Product Sales Volume (K Units) (2012-2017)
Table United States Bio-protein Drug Sales (K Units) of Key Players/Suppliers (2012-2017)
Table United States Bio-protein Drug Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Bio-protein Drug Sales Share by Players/Suppliers
Figure 2017 United States Bio-protein Drug Sales Share by Players/Suppliers
Figure United States Bio-protein Drug Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Bio-protein Drug Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Bio-protein Drug Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Bio-protein Drug Revenue Share by Players/Suppliers
Figure 2017 United States Bio-protein Drug Revenue Share by Players/Suppliers
Table United States Market Bio-protein Drug Average Price (USD/Unit) of Key Players/Suppliers (2012-2017)
Figure United States Market Bio-protein Drug Average Price (USD/Unit) of Key Players/Suppliers in 2016
Figure United States Bio-protein Drug Market Share of Top 3 Players/Suppliers
Figure United States Bio-protein Drug Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Bio-protein Drug Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Bio-protein Drug Product Category
Table United States Bio-protein Drug Sales (K Units) by Region (2012-2017)
Table United States Bio-protein Drug Sales Share by Region (2012-2017)
Figure United States Bio-protein Drug Sales Share by Region (2012-2017)
Figure United States Bio-protein Drug Sales Market Share by Region in 2016
Table United States Bio-protein Drug Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Bio-protein Drug Revenue Share by Region (2012-2017)
Figure United States Bio-protein Drug Revenue Market Share by Region (2012-2017)
Figure United States Bio-protein Drug Revenue Market Share by Region in 2016
Table United States Bio-protein Drug Price (USD/Unit) by Region (2012-2017)
Table United States Bio-protein Drug Sales (K Units) by Type (2012-2017)
Table United States Bio-protein Drug Sales Share by Type (2012-2017)
Figure United States Bio-protein Drug Sales Share by Type (2012-2017)
Figure United States Bio-protein Drug Sales Market Share by Type in 2016
Table United States Bio-protein Drug Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Bio-protein Drug Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Bio-protein Drug by Type (2012-2017)
Figure Revenue Market Share of Bio-protein Drug by Type in 2016
Table United States Bio-protein Drug Price (USD/Unit) by Types (2012-2017)
Figure United States Bio-protein Drug Sales Growth Rate by Type (2012-2017)
Table United States Bio-protein Drug Sales (K Units) by Application (2012-2017)
Table United States Bio-protein Drug Sales Market Share by Application (2012-2017)
Figure United States Bio-protein Drug Sales Market Share by Application (2012-2017)
Figure United States Bio-protein Drug Sales Market Share by Application in 2016
Table United States Bio-protein Drug Sales Growth Rate by Application (2012-2017)
Figure United States Bio-protein Drug Sales Growth Rate by Application (2012-2017)
Table Abbott Laboratories Basic Information List
Table Abbott Laboratories Bio-protein Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Abbott Laboratories Bio-protein Drug Sales Growth Rate (2012-2017)
Figure Abbott Laboratories Bio-protein Drug Sales Market Share in United States (2012-2017)
Figure Abbott Laboratories Bio-protein Drug Revenue Market Share in United States (2012-2017)
Table Bayer AG Basic Information List
Table Bayer AG Bio-protein Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Bayer AG Bio-protein Drug Sales Growth Rate (2012-2017)
Figure Bayer AG Bio-protein Drug Sales Market Share in United States (2012-2017)
Figure Bayer AG Bio-protein Drug Revenue Market Share in United States (2012-2017)
Table Eli Lilly and Company Basic Information List
Table Eli Lilly and Company Bio-protein Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Eli Lilly and Company Bio-protein Drug Sales Growth Rate (2012-2017)
Figure Eli Lilly and Company Bio-protein Drug Sales Market Share in United States (2012-2017)
Figure Eli Lilly and Company Bio-protein Drug Revenue Market Share in United States (2012-2017)
Table Amgen Inc. Basic Information List
Table Amgen Inc. Bio-protein Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Amgen Inc. Bio-protein Drug Sales Growth Rate (2012-2017)
Figure Amgen Inc. Bio-protein Drug Sales Market Share in United States (2012-2017)
Figure Amgen Inc. Bio-protein Drug Revenue Market Share in United States (2012-2017)
Table Biocon Ltd. Basic Information List
Table Biocon Ltd. Bio-protein Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Biocon Ltd. Bio-protein Drug Sales Growth Rate (2012-2017)
Figure Biocon Ltd. Bio-protein Drug Sales Market Share in United States (2012-2017)
Figure Biocon Ltd. Bio-protein Drug Revenue Market Share in United States (2012-2017)
Table Dr. Reddy’s Laboratories Basic Information List
Table Dr. Reddy’s Laboratories Bio-protein Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Dr. Reddy’s Laboratories Bio-protein Drug Sales Growth Rate (2012-2017)
Figure Dr. Reddy’s Laboratories Bio-protein Drug Sales Market Share in United States (2012-2017)
Figure Dr. Reddy’s Laboratories Bio-protein Drug Revenue Market Share in United States (2012-2017)
Table Roche Basic Information List
Table Roche Bio-protein Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Roche Bio-protein Drug Sales Growth Rate (2012-2017)
Figure Roche Bio-protein Drug Sales Market Share in United States (2012-2017)
Figure Roche Bio-protein Drug Revenue Market Share in United States (2012-2017)
Table Fresenius kabi Basic Information List
Table Fresenius kabi Bio-protein Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Fresenius kabi Bio-protein Drug Sales Growth Rate (2012-2017)
Figure Fresenius kabi Bio-protein Drug Sales Market Share in United States (2012-2017)
Figure Fresenius kabi Bio-protein Drug Revenue Market Share in United States (2012-2017)
Table GlaxoSmithKline Basic Information List
Table GlaxoSmithKline Bio-protein Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure GlaxoSmithKline Bio-protein Drug Sales Growth Rate (2012-2017)
Figure GlaxoSmithKline Bio-protein Drug Sales Market Share in United States (2012-2017)
Figure GlaxoSmithKline Bio-protein Drug Revenue Market Share in United States (2012-2017)
Table Johnson & Johnson Basic Information List
Table Johnson & Johnson Bio-protein Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Johnson & Johnson Bio-protein Drug Sales Growth Rate (2012-2017)
Figure Johnson & Johnson Bio-protein Drug Sales Market Share in United States (2012-2017)
Figure Johnson & Johnson Bio-protein Drug Revenue Market Share in United States (2012-2017)
Table Merck Basic Information List
Table Novartis AG Basic Information List
Table Panacea Biotec Basic Information List
Table ProBioGen AG Basic Information List
Table Sanofi Basic Information List
Table Reliance Life Science Pvt. Ltd. Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Bio-protein Drug
Figure Manufacturing Process Analysis of Bio-protein Drug
Figure Bio-protein Drug Industrial Chain Analysis
Table Raw Materials Sources of Bio-protein Drug Major Players/Suppliers in 2016
Table Major Buyers of Bio-protein Drug
Table Distributors/Traders List
Figure United States Bio-protein Drug Sales Volume (K Units) and Growth Rate Forecast (2017-2022)
Figure United States Bio-protein Drug Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Bio-protein Drug Price (USD/Unit) Trend Forecast (2017-2022)
Table United States Bio-protein Drug Sales Volume (K Units) Forecast by Type (2017-2022)
Figure United States Bio-protein Drug Sales Volume (K Units) Forecast by Type (2017-2022)
Figure United States Bio-protein Drug Sales Volume (K Units) Forecast by Type in 2022
Table United States Bio-protein Drug Sales Volume (K Units) Forecast by Application (2017-2022)
Figure United States Bio-protein Drug Sales Volume (K Units) Forecast by Application (2017-2022)
Figure United States Bio-protein Drug Sales Volume (K Units) Forecast by Application in 2022
Table United States Bio-protein Drug Sales Volume (K Units) Forecast by Region (2017-2022)
Table United States Bio-protein Drug Sales Volume Share Forecast by Region (2017-2022)
Figure United States Bio-protein Drug Sales Volume Share Forecast by Region (2017-2022)
Figure United States Bio-protein Drug Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

United States Bio-protein Drug Market Report 2017

More Publications

Need Help?

Ask a Question

Market Reports